WeVote
Log In

Bill

Bill

S 800

An Act relative to pharmacists as healthcare providers

194th Legislature (2025-2026) Introduced by Mike Moore and 1 co-sponsor

Massachusetts bill would designate pharmacists as healthcare providers, expanding their clinical authority and integration into the state's healthcare system.

Accompanied a study order, see S2972
0
WeVote Research Nonpartisan
Bill Summary · S 800

Legislative bill overview

S 800 seeks to recognize pharmacists as healthcare providers in Massachusetts, expanding their scope of practice and professional authority. The bill has been referred to the Financial Services Committee and is scheduled for a hearing on April 29, 2025. This legislation would formally integrate pharmacists into the state's healthcare delivery system with enhanced clinical responsibilities.

Why is this important

Pharmacists represent an accessible healthcare resource in nearly every community, and expanded scope could increase preventive care access and reduce physician burden for routine clinical tasks. The designation could affect insurance reimbursement, prescribing authority, collaborative agreements with doctors, and patient care protocols across Massachusetts healthcare settings.

Potential points of contention

  • Scope of practice boundaries: Defining exactly what clinical services pharmacists can independently provide without physician oversight (immunizations, medication adjustments, diagnostics, etc.) and where physician collaboration remains mandatory
  • Liability and accountability framework: Questions about malpractice insurance requirements, professional liability standards, and oversight mechanisms to ensure patient safety and quality control
  • Insurance and payment implications: How insurance companies will reimburse pharmacist services, whether this increases healthcare costs or reduces them, and potential shifts in profit margins across the healthcare system
  • Professional turf concerns: Potential resistance from physicians, nurse practitioners, and other providers who may view expanded pharmacist authority as competitive rather than collaborative

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.